Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
10+ emerging markets, Japan & ANZ transition in final phase
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Receives registration of Valganciclovir powder for oral solution in Germany
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Expands patient reach to remotest towns by furthering investment in GoApptiv
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Subscribe To Our Newsletter & Stay Updated